Highlights
NASDAQ: MRNS       Marinus Pharma CS
Last Price Today's Change   Day's Range   Trading Volume
2.13   +0.06 (2.90%)  2.065 - 2.13  201,679

Overview

 
Avg Volume (4 weeks):1,176,122
4 Weeks Range:1.92 - 2.50
4 Weeks Price Volatility (%):
36.21%
52 Weeks Range:0.77 - 5.40
52 Weeks Price Volatility (%):
29.37%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Marinus Pharmaceuticals Inc is a clinical stage biopharmaceutical company. It is focused on developing and commercializing innovative therapeutics to treat epilepsy and neuropsychiatric disorders. Marinus manages the business in one segment, which is the identification and development of neuropsychiatric therapeutics. The Company is developing ganaxolone for multiple epilepsy and other neuropsychiatric indications, including adjunctive, or add-on, therapy for the treatment of drug-resistant focal onset seizures; status epilepticus; Fragile X Syndrome, and PCDH19 pediatric epilepsy.

  Be the first to like this.
 


 

3268  2299  435  2960 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 CELG 108.24+0.11 
 ACHN 6.760.00 
 AVP 5.60-0.05 
 AABA 19.630.00 
 VIAB 24.22+0.75 
 ECA 3.79-0.25 
 PFE 38.48-1.68 
 VXRT 0.842+0.20 
 NIO 4.145+0.135 
 F 8.92+0.03 
Partners & Brokers